BMJ · 1977 · 77 citations · 4 references
PharmacyBiochemistryPharmacologyAgingDrug MetabolismGerontologyAge-related Pharmacokinetic DifferencesAge-related PharmacokineticsAge-related Physiological ChangesHepatic MetabolismLiver DiseasePharmacokinetics In Liver DiseaseAge-dependent Drug DispositionDrug AcetylationHalf-life Variation With AgeHepatic AgingHepatic Drug DispositionHepatic Function ChangesHepatic Half-lifeLiver Metabolism In Aging
The half lives of acetanilide and isoniazid ("model" substrates for oxidation and acetylation respectively) were measured in populations of young (aged 20-35 years) and elderly (aged over 65 years) people. Whereas acetanilide half lives were significantly longer in the elderly, isoniazid half lives were distributed similarly in both populations. The results suggest that liver function does not decline uniformly with age and that heterozygotes for acetylation do not possess survival advantages during their middle years of life.
4
Genetic Control of Isoniazid Metabolism in Man
David A. Evans, K. A. Manley, V.A. McKusick · BMJ · 1960 · 791 citations · Full text
Correlation of Subjective Side Effects with Plasma Concentrations of Nortriptyline
Marie Åsberg, Börje Cronholm, Folke Sjöqvist et al. · BMJ · 1970 · 204 citations · Full text
Medicine, Pharmacology, Psychiatry +15
Genetic Control of Phenylbutazone Metabolism in Man
J. A. Whittaker, David A. Evans · BMJ · 1970 · 73 citations · Full text